TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive In Brief: DCT Reorganizing Some Labs, Branches, Plans to Establish Theirs; Weicker, Natcher Honored January 17, 1986